[EN] Lung cancer is a malignant disease with high mortality and poor prognosis, frequently diagnosed at advanced stages. Nowadays, immense progress in treatment has been achieved. However, the present scenario continues ...
Vicente, Oscar; Boscaiu, Monica(University of Agronomic Sciences and Veterinary Medicine of Bucharest, Romania - Faculty of Biotechnologies, 2017)
[EN] The use of genetically modified organisms (GMOs) as biofactories for the production of recombinant proteins of
commercial interest is at present one of the major applications of `molecular¿ biotechnology, and the ...
López Riera, Mireia(Universitat Politècnica de València, 2016-06-13)
[EN] Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disease in Western countries. It has a prevalence of 20-30% in the
general population, which rises up to a 70-90% in patients ...
Duréndez Sáez, María Elena(Universitat Politècnica de València, 2024-03-31)
[ES] A pesar de los nuevos avances en el tratamiento del cáncer de pulmón, su tasa de incidencia y mortalidad siguen en cabeza en todo mundo. Concretamente, el cáncer de pulmón no microcítico (CPNM) representa casi el 85% ...
Climent Terol, Estela; Mondragón Martínez, Laura; Martínez Mañez, Ramón; Sancenón Galarza, Félix; Marcos Martínez, María Dolores; Murguía Ibáñez, José Ramón; Amoros del Toro, Pedro Jose; Rurack, Knut; Pérez Payá, Enrique(Wiley-VCH Verlag, 2013-07-10)
The coupling of gated-indicator delivery with highly specific biochemical recognition is an innovative strategy for the detection of DNA sequences, able to compete with classical methods which need PCR amplification, in ...